Pharma Market In Belgium Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Belgium Pharmaceutical Industry Report Overview & Analysis. The Market is Segmented by ATC/Therapeutic Class (Alimentary Tract and Metabolism?, Blood and Blood Forming Organs?, Cardiovascular System?, Dermatological?s, Genito Urinary System and Sex Hormones?, Systemic Hormonal Preparations?, Anti-Infectives for Systemic Use?, Antineoplastic and Immunomodulating Agents?, Musculoskeletal System?, Nervous System?, Antiparasitic Products, Insecticides, and Repellents?, Respiratory System?, Sensory Organs?, and Other Therapeutic Classes) and Drug Type (Prescription Drugs (Branded and Generics) and OTC)). The Market Size and Forecasts are Provided in Terms of Value (USD Million) for all the Above Segments.

Pharma Market In Belgium Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Belgium Pharmaceutical Market Size

Belgium Pharmaceutical Market Summary
Study Period 2020 - 2030
Market Size (2025) USD 8.40 Billion
Market Size (2030) USD 11.17 Billion
CAGR (2025 - 2030) 5.87 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Belgium Pharmaceutical Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Belgium Pharmaceutical Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Belgium Pharmaceutical Market Analysis

The Belgium Pharmaceutical Market size is estimated at USD 8.40 billion in 2025, and is expected to reach USD 11.17 billion by 2030, at a CAGR of 5.87% during the forecast period (2025-2030).

Belgium is expected to hold a significant share of the European pharmaceutical market. The market is anticipated to grow due to factors such as increasing expenditures on healthcare and medicines and the rising burden of diseases in the country.

Belgium's pharmaceutical market has established itself as a global leader, driven by significant investments in research and development. For instance, according to the data published by the International Trade Administration (ITA), United States Department of Commerce in January 2024, Belgium's pharmaceutical sector invests USD 1.64 billion annually in research and development, representing 40% of all private investment in the country. Consequently, Belgium hosts 29 of the world's top 30 pharmaceutical companies, including significant subsidiaries of major United States corporations such as Johnson & Johnson and Pfizer. Therefore, it is anticipated that the creation of novel pharmaceuticals due to Belgium's increasing R&D spending will fuel the market's expansion.

Further, the growing prevalence of chronic diseases such as cancer and diabetes in Belgium is anticipated to fuel the expansion of the country's pharmaceutical industry. For instance, according to data published by the Global Cancer Observatory (GCO) in February 2024, reported that there were 84.3 thousand new cases of cancer are expected to be diagnosed by 2025 in Belgium, further reaching 90.6 thousand new cancer cases by 2030. Additionally, a study published in the Population Health Metrics in April 2024, estimated that 9.93 thousand people in Belgium will have diabetes by 2030. This increasing burden of chronic diseases is expected to significantly boost the demand for innovative pharmaceutical solutions, thereby driving the growth of Belgium's pharmaceutical market.

Therefore, the rising research and development expenditure and rising prevalence of chronic diseases such as cancers and diabetes, among others are expected to drive the growth of Belgium pharmaceutical market over the forecast period. However, socioeconomic inequality is expected to restraint the market growth in Belgium.

Belgium Pharmaceutical Industry Overview

The Belgium pharmaceutical market is highly competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some of the key companies currently dominating the market are AbbVie Inc., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, and GlaxoSmithKline PLC, among others.

Belgium Pharmaceutical Market Leaders

  1. AstraZeneca plc

  2. AbbVie Inc.

  3. Bayer AG

  4. GlaxoSmithKline plc

  5. Boehringer Ingelheim International GmbH

  6. *Disclaimer: Major Players sorted in no particular order
Belgium Pharmaceutical Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Belgium Pharmaceutical Market News

  • June 2024: Gedeon Richter Plc. completed the acquisition of BCI Pharma, a privately owned biotech company based in Belgium that conducts innovative research on various women's health issues. This acquisition aligned strategically to create a new standard for precision treatments in women's health.
  • May 2024: The pharmaceutical project Med4Cure initiative received approval from the European Commission, public funding of nearly USD 1.1 billion was distributed among 13 participating companies, including OncoRNA from Belgium. This investment aims to catalyze an extra USD 6.5 billion (EUR 5.9 billion) in private investment.

Belgium Pharmaceutical Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
    • 4.1.1 Healthcare Expenditure (Govt. Vs Private)
    • 4.1.2 Pharmaceutical Imports and Exports
    • 4.1.3 Epidemiology Data for Key Diseases
    • 4.1.4 Regulatory Landscape/Regulatory Bodies
    • 4.1.5 Licensing and Market Authorization (For both Local Production and Imported Goods)
    • 4.1.6 Pipeline Analysis
    • 4.1.6.1 By Phase
    • 4.1.6.2 By Sponsor
    • 4.1.6.3 By Disease
    • 4.1.7 Statistical Overview
    • 4.1.7.1 Number of Hospitals
    • 4.1.7.2 Employment in the Pharmaceutical Sector
    • 4.1.7.3 R&D Expenditure
    • 4.1.8 Ease of Doing Business
  • 4.2 Market Drivers
    • 4.2.1 Increasing Expenditure on Healthcare and Medicines
    • 4.2.2 Rising Burden of Chronic Diseases
  • 4.3 Market Restraints
    • 4.3.1 Socioeconomic Inequality
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By ATC/Therapeutic Class
    • 5.1.1 Alimentary Tract and Metabolism
    • 5.1.2 Blood and Blood Forming Organs
    • 5.1.3 Cardiovascular System
    • 5.1.4 Dermatologicals
    • 5.1.5 Genito Urinary System
    • 5.1.6 Systemic Hormonal Preparations
    • 5.1.7 Nervous System
    • 5.1.8 Musculoskeletal System
    • 5.1.9 Respiratory System
    • 5.1.10 Other ATC/ Therapeutic Class
  • 5.2 By Drug Type
    • 5.2.1 Prescription Drugs
    • 5.2.1.1 Branded
    • 5.2.1.2 Generics
    • 5.2.2 OTC

6. COMPETITIVE LANDSCAPE AND COMPANY PROFILES

  • 6.1 Company Profiles
    • 6.1.1 AbbVie Inc.
    • 6.1.2 AstraZeneca PLC
    • 6.1.3 Bayer AG
    • 6.1.4 Boehringer Ingelheim International GmbH
    • 6.1.5 GlaxoSmithKline PLC
    • 6.1.6 F. Hoffmann-La Roche AG
    • 6.1.7 Bristol Myers Squibb Company
    • 6.1.8 Eli Lilly and Company
    • 6.1.9 Merck & Co. Inc.
    • 6.1.10 Sanofi SA
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Belgium Pharmaceutical Industry Segmentation

As per the scope of this report, pharmaceuticals are referred to as prescribed and non-prescribed drugs. These medicines can be bought by an individual with or without the doctor's prescription and are safe for consumption for various illnesses. The Belgium Pharmaceutical Market is segmented by ATC/therapeutic class and drug type. By ATC/therapeutic class, the market is segmented into alimentary tract and metabolism, blood and blood-forming organs, cardiovascular system, dermatologicals, genito urinary system, systemic hormonal preparations,nervous system, musculoskeletal system, respiratory system, and other therapeutic classes. By drug type, the market is segmented into prescription drugs and OTC. By prescription drugs, the market is sub-segmented into branded and generics. For each segment, the market size is provided in terms of USD value.

By ATC/Therapeutic Class Alimentary Tract and Metabolism
Blood and Blood Forming Organs
Cardiovascular System
Dermatologicals
Genito Urinary System
Systemic Hormonal Preparations
Nervous System
Musculoskeletal System
Respiratory System
Other ATC/ Therapeutic Class
By Drug Type Prescription Drugs Branded
Generics
OTC
Need A Different Region or Segment?
Customize Now

Belgium Pharmaceutical Market Research FAQs

How big is the Belgium Pharmaceutical Market?

The Belgium Pharmaceutical Market size is expected to reach USD 8.40 billion in 2025 and grow at a CAGR of 5.87% to reach USD 11.17 billion by 2030.

What is the current Belgium Pharmaceutical Market size?

In 2025, the Belgium Pharmaceutical Market size is expected to reach USD 8.40 billion.

Who are the key players in Belgium Pharmaceutical Market?

AstraZeneca plc, AbbVie Inc., Bayer AG, GlaxoSmithKline plc and Boehringer Ingelheim International GmbH are the major companies operating in the Belgium Pharmaceutical Market.

Which is the fastest growing region in Belgium Pharmaceutical Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Belgium Pharmaceutical Market?

In 2025, the North America accounts for the largest market share in Belgium Pharmaceutical Market.

What years does this Belgium Pharmaceutical Market cover, and what was the market size in 2024?

In 2024, the Belgium Pharmaceutical Market size was estimated at USD 7.91 billion. The report covers the Belgium Pharmaceutical Market historical market size for years: 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Belgium Pharmaceutical Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Belgium Pharmaceutical Market Report Snapshots